SCHEMBL7928392

SCHEMBL7928392

COC(=O)c1ccc(C#CC(=O)c2ccc3c(c2)CCCC3(C)C)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.40
RXRB P28702 2/20 0.40
RXRG P48443 2/20 0.40
CYP3A4 P08684 4/20 0.39
RARB P10826 3/20 0.38
CYP26A1 O43174 3/20 0.38
RARG P13631 2/20 0.38
RARA P10276 1/20 0.38
CRABP2 P29373 1/20 0.38
PDK2 Q15119 2/20 0.37
PDK4 Q16654 2/20 0.37
PDK1 Q15118 1/20 0.37
PDK3 Q15120 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7937802 0.93 RXRA (0.41) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7751118 0.89 RARB (0.45) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7717535 0.87 CYP3A4 (0.52) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7746411 0.82 RXRA (0.45) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7928435 0.81 PDK2 (0.35) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7714846 0.80 RARA (0.52) RXRACYP3A4RARBCYP26A1RARG
SCHEMBL7936336 0.77 PDK2 (0.37) RXRARXRBRXRGCYP3A4RARB
SCHEMBL19342969 0.76 RARB (0.56) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7940029 0.76 PDK2 (0.36) RXRARXRBRXRGCYP3A4RARB
SCHEMBL7714910 0.75 RARB (0.58) RXRARXRBRXRGCYP3A4RARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313162-B1 FOR USE IN HUMAN OR VETERINARY MEDICINE SUCH AS DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHHALMOLOGICAL DISORDERS; AND IN COSMETICS CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) GALDERMA (FR) 2001-11-06 US disclosed
US-6046220-A ADMINISTERING TO THE PATIENT A PROPYNYL OR DIENYL BIAROMATIC COMPOUND TO TREAT A SKIN DISORDER, INFLAMMATORY CONDITIONS, VISION DEFECTS, ALOPECIA, CARDIOVASCULAR DISORDER, CANCER OR PRECANCER AND INSULIN DEPENDANT DIABETES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-04-04 US disclosed